Modified Nucleosides as Tumor Markers for Cancer Diagnosis
Author Information
Author(s): Seidel A, Brunner S, Seidel P, Fritz G I, Herbarth O
Primary Institution: University of Leipzig
Hypothesis
Can modified nucleosides in urine serve as effective tumor markers for cancer diagnosis?
Conclusion
Modified nucleosides in urine can be used as effective tumor markers for early cancer detection and therapy monitoring.
Supporting Evidence
- Modified nucleosides were found in higher concentrations in the urine of cancer patients compared to healthy individuals.
- The study achieved a sensitivity of 97% and specificity of 85% using neural network analysis.
- Urinary nucleosides showed higher diagnostic sensitivity than traditional tumor markers like CEA and CA 15-3.
Takeaway
Doctors can check for special substances in your pee to see if you might have cancer. It's like a secret code that helps them find out if you're sick.
Methodology
The study analyzed urine samples from cancer patients and healthy controls using high-performance liquid chromatography to measure modified nucleosides.
Potential Biases
Potential misclassification of healthy individuals as cancer patients due to overlapping nucleoside levels.
Limitations
The study may not account for other conditions that influence RNA catabolism, which could lead to false positives.
Participant Demographics
55 cancer patients (ages 17-85, mean age 56.9) and 41 healthy controls (ages 25-70, mean age 38.4).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website